SCHEMBL19079830

SCHEMBL19079830

C=C(C)Cn1c(SCC(=O)c2ccccc2)nc2sc3c(c2c1=O)CCOC3

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 3/20 0.79
▸ TP53 P04637 2/20 0.79
▸ SMN1; SMN2 Q16637 1/20 0.79
▸ RXFP1 Q9HBX9 1/20 0.66
▸ MAPT P10636 8/20 0.64
▸ KDM4E B2RXH2 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CNR1 P21554 1/20 0.54
▸ WEE1 P30291 1/20 0.49
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ POLB P06746 1/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ APEX1 P27695 1/20 0.46
▸ APOBEC3A P31941 1/20 0.46
▸ PTPN7 P35236 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079698 0.88 PDE4D (1.00) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079829 0.88 PDE4D (0.79) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079840 0.85 PDE4D (0.79) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079702 0.83 PDE4D (0.90) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079828 0.83 TSHR (0.63) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079708 0.80 PDE4D (0.85) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19088672 0.80 RXFP1 (0.85) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079779 0.80 RXFP1 (0.84) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079836 0.79 PDE4D (0.83) PDE4DTP53SMN1; SMN2RXFP1MAPT
SCHEMBL19079783 0.77 PDE4D (0.80) PDE4DTP53SMN1; SMN2RXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885TP53 4300/4885SMN1; SMN2 4025/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885TP53 4300/4885SMN1; SMN2 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback